Clinical Trial Update: Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists [Phase 4]

View source ↗

Summary

Phase 4 trial investigating ADRB2 Gly16Arg polymorphism impact on asthma control in children on long-acting beta agonists; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Safety of Long Acting Beta Agnoists | Phase 4 | Status: WITHDRAWN